Cargando…
CB2 Receptors and Neuron–Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition
Monoacylglycerol lipase inhibition (MAGL) has emerged as an interesting therapeutic target for neurodegenerative disease treatment due to its ability to modulate the endocannabinoid system and to prevent the production of proinflammatory mediators. To obtain a beneficial response, it is necessary to...
Autores principales: | Rojo-Bustamante, Estefania, Íñigo-Marco, Ignacio, Abellanas, Miguel Angel, Vinueza-Gavilanes, Rodrigo, Baltanás, Ana, Luquin, Esther, Arrasate, Montserrat, Aymerich, Maria S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464766/ https://www.ncbi.nlm.nih.gov/pubmed/32824740 http://dx.doi.org/10.3390/biom10081198 |
Ejemplares similares
-
Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis
por: Bugallo, Ricardo, et al.
Publicado: (2020) -
Microglia and astrocyte activation is region‐dependent in the α‐synuclein mouse model of Parkinson's disease
por: Basurco, Leyre, et al.
Publicado: (2022) -
Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties
por: Barth, Maximilian, et al.
Publicado: (2022) -
New Disulfiram Derivatives as MAGL-Selective Inhibitors
por: Omran, Ziad
Publicado: (2021) -
Brain structural changes in cannabis dependence: association with MAGL
por: Manza, Peter, et al.
Publicado: (2019)